Adaptive Biotechnologies CorporationADPTNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-128.76M
Near historical average
Average (7y)
$-122.89M
Historical baseline
Range
High:$-37.84M
Low:$-193.34M
CAGR
+19.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-128.76M | +32.0% |
| 2023 | $-189.27M | -8.0% |
| 2022 | $-175.21M | +9.4% |
| 2021 | $-193.34M | -33.9% |
| 2020 | $-144.34M | -104.5% |
| 2019 | $-70.60M | -61.3% |
| 2018 | $-43.76M | -15.6% |
| 2017 | $-37.84M | - |